极速赛车

Health 极速赛车 provides breaking legal news and analysis on the health care industry. Coverage includes litigation, policy developments, and corporate deals involving health care services companies such as hospitals, health insurers, physicians groups, and medical suppliers.

Sign up for a 7-day FREE trial today!

Latest News in Health

• July 31, 2025

  Justices Told State Med Mal Laws Fly In Federal Court

  A Delaware federal court must apply a state statute requiring an expert affidavit in all medical malpractice suits, a hospital defendant told the U.S. Supreme Court, as key aspects of the Delaware law and similar statutes in 28 other states "should not be checked at the federal courthouse doors."

• July 31, 2025

  Flo Settles Privacy Fight Midtrial, Leaving Meta To Face Jury

  Flo Health Inc. told a California federal judge Thursday it had reached an agreement to settle claims that its popular menstrual-tracking app illegally shared sensitive health data of millions of women with Meta Platforms Inc. and Google, partially resolving a sweeping privacy case midtrial, and leaving Meta as the sole remaining defendant.

• July 31, 2025

  Walnut Co. Says Firm Misled Court To Lead Super Micro Case

  A Hagens Berman client who lost the fight against Universal Investment to lead investor claims against Super Micro Computer has blasted the fund's opposition to its bid for a California federal judge to reconsider the denial, arguing Universal's attorneys from聽Bernstein Litowitz Berger & Grossmann LLP have a "documented history" of "misleading courts."

• July 31, 2025

  Hospitals Want To Duck Pharmacy Career Match Program Suit

  A professional pharmacy organization and a group of teaching hospitals teed up motions to dismiss Wednesday against proposed class action allegations that they conspired to restrict wages and benefits by funneling new pharmacists through a job-matching program, telling a Maryland federal judge that there's no sign of an agreement.

• July 31, 2025

  Biotech Co. Beats Investor Suit Over Antifungal Drug Recall

  Biotechnology company Scynexis Inc. has won dismissal, for now, of a proposed investor class action alleging that it triggered a 34% share decline by knowingly misleading investors about manufacturing compliance issues that led to a drug recall, with the court finding the allegations the company should have known and disclosed issues only show "fraud by hindsight."

See more Health news